Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Morty Cohen"'
Autor:
Steven M Rowe, Bo Liu, Aubrey Hill, Heather Hathorne, Morty Cohen, John R Beamer, Frank J Accurso, Qunming Dong, Claudia L Ordoñez, Anne J Stone, Eric R Olson, John P Clancy, VX06-770-101 Study Group
Publikováno v:
PLoS ONE, Vol 8, Iss 7, p e66955 (2013)
Nasal potential difference (NPD) is used as a biomarker of the cystic fibrosis transmembrane conductance regulator (CFTR) and epithelial sodium channel (ENaC) activity. We evaluated methods to detect changes in chloride and sodium transport by NPD ba
Externí odkaz:
https://doaj.org/article/0a91e14016b6404f889b4e85926f8847
Coefficients of Fat and Nitrogen Absorption in Healthy Subjects and Individuals with Cystic Fibrosis
Autor:
Anna O'Rourke, Morty Cohen, Leslie Hendeles, Michael W. Konstan, Frederick T. Murray, Drucy Borowitz
Publikováno v:
The Journal of Pediatric Pharmacology and Therapeutics. 12:47-52
BACKGROUND We sought to compare the differences of coefficient of fat absorption (CFA) and coefficient of nitrogen absorption (CNA) in healthy individuals and those with cystic fibrosis (CF) and to study the precision of CFA and CNA.METHODS Sixteen h
Autor:
Jane L. Burns, Morty Cohen, Trish Hasbrouck, Jenny R. Stapp, Julia Emerson, Pamela L. Zeitlin, Judy Williams, Bonnie W. Ramsey, Iris Osberg, Michael W. Konstan, Vikki Kociela, Jessica Foster, Nicole Hamblett, George Z. Retsch-Bogart, Jean Mundahl, Richard B. Moss, Marcia Wertz, W. Craig Johnson, Mark Dovey, Churee Penvari, Peter Hiatt, Sally Locke, Jeffrey S. Wagener, Sharon McNamara, Ann Yunker, Charlene Hallmark, Frank J. Accurso, Kate Hilliard, Robert W. Wilmott, Sharon L. Watts, Margaret Rosenfeld, Richard A. Kronmal, Lori Ingham, David Waltz, Ronald L. Gibson, Jay B. Hilliard
Publikováno v:
American Journal of Respiratory and Critical Care Medicine. 167:841-849
We conducted a double-blind, placebo-controlled, multicenter, randomized trial to test the hypothesis that 300 mg of tobramycin solution for inhalation administered twice daily for 28 days would be safe and result in a profound decrease in Pseudomona
Publikováno v:
Clinical Pulmonary Medicine. 4:101-112
Publikováno v:
Journal of pediatric gastroenterology and nutrition. 56(3)
Inflammatory bowel disease (IBD) is characterized by chronic intestinal inflammation in the absence of a recognized etiology. The primary therapies are medications that possess anti-inflammatory or immunosuppressive effects. Given the high use of com
Autor:
Francine Won, Ross M. Hays, Morty Cohen, John F. McLaughlin, Cathy Graubert, Robert Price, Kristie Bjornson
Publikováno v:
Pediatrics. 120(1)
BACKGROUND. Spasticity is a prevalent disabling clinical symptom for children with cerebral palsy. Treatment of spasticity with botulinum toxin in children with cerebral palsy was first reported in 1993. Botulinum toxin provides a focal, controlled m
Autor:
Joseph M. Pilewski, Richard C. Ahrens, Richard Markus, Christopher M. Oermann, Tracy L. Callahan, Jane L. Burns, George Z. Retsch-Bogart, Carlos Milla, Morty Cohen, Sharon McNamara, Ronald L. Gibson, Kevin Leon, Cori L. Daines
Publikováno v:
Pediatric pulmonology. 41(7)
Background Aztreonam lysinate for inhalation (AI) is a novel monobactam formulation being investigated for pulmonary Pseudomonas aeruginosa infections in patients with cystic fibrosis (CF). Methods Pre-clinical studies investigated the pre- and post-
Autor:
Carolyn A. Paris, Eileen J. Klein, Linda Quan, Douglas S. Diekema, Kristy Seidel, Morty Cohen
Publikováno v:
Pediatrics. 109(5)
Objective. To determine whether a combination of oral transmucosal fentanyl (Fentanyl Oralet, Abbott Laboratories, North Chicago, IL) plus oral midazolam has an acceptable safety profile and is more effective than oral midazolam alone for sedation du
Autor:
Bonnie W. Ramsey, Judy Williams-Warren, Morty Cohen, Allan Weber, Greg Morlin, Arnold L. Smith
Publikováno v:
Pediatric pulmonology. 23(4)
We compared the performance of selected ultrasonic and jet nebulizers when aerosolizing several antibiotic formulations to determine optimum combinations for delivery of a respirable antibiotic aerosol. Three ultrasonic devices were tested: the Ultra
Autor:
Rimmie Pandher, Morty Cohen, Arnold L. Smith, Bonnie W. Ramsey, Allan Weber, Judy Williams-Warren
Publikováno v:
Infection. 25(2)
Ciprofloxacin, an orally-absorbed fluoroquinolone is effective against multiply resistantPseudomonas aeruginosa in cystic fibrosis patients. It is the only practicable agent against extraintestinal salmonellosis and shigellosis in developing countrie